Ngenla 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification
Decision 
Information 
1 issued on 
Issued2 / 
affected3  
amended 
on 
IB/0007 
C.I.z - Changes (Safety/Efficacy) of Human and 
05/12/2022 
SmPC and PL 
Veterinary Medicinal Products - Other variation 
PSUSA/10982
Periodic Safety Update EU Single assessment - 
01/12/2022 
n/a 
PRAC Recommendation - maintenance 
/202204 
somatrogon 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
IB/0006 
B.I.z - Quality change - Active substance - Other 
10/11/2022 
n/a 
variation 
N/0004 
Minor change in labelling or package leaflet not 
31/08/2022 
PL 
connected with the SPC (Art. 61.3 Notification) 
II/0001/G 
This was an application for a group of variations. 
21/07/2022 
n/a 
B.I.c.1.b - Change in immediate packaging of the AS 
- Qualitative and/or quantitative composition for 
sterile and non-frozen biological/immunological ASs 
B.II.b.3.a - Change in the manufacturing process of 
the finished or intermediate product - Minor change 
in the manufacturing process 
B.I.a.3.c - Change in batch size (including batch size 
ranges) of AS or intermediate - The change requires 
assessment of the comparability of a 
biological/immunological AS 
B.I.d.1.b.2 - Stability of AS - Change in the storage 
conditions - Change in storage conditions of 
biological/immunological ASs, when the stability 
studies have not been performed in accordance with 
a currently approved stability protocol 
N/0003 
Minor change in labelling or package leaflet not 
25/03/2022 
Labelling and 
connected with the SPC (Art. 61.3 Notification) 
IA/0002 
A.6 - Administrative change - Change in ATC 
18/03/2022 
Code/ATC Vet Code 
PL 
SmPC 
Page 2/2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
